Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications
The FASEB Journal · 15.05.2025 · 39 (9)
DOI: 10.1096/fj.202500024r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 05.05.2025. Verfasst von Brusi Kola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA. Hauptthemen laut MEDLINE: Lymphangiogenesis, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: Breast Cancer Research Foundation of Alabama (BCRFA), University of South Alabama (USA).
Abstract (Originalsprache)
Despite the recent advances in treatment, breast cancer (BCa) remains a leading cause of cancer‐related mortality worldwide, and metastasis accounts for the most significant number of BCa deaths. Lymphangiogenesis, the process by which new lymphatic vessels develop from pre‐existing ones, is a major driver of BCa metastasis. High lymphatic vessel density is linked to lymph node metastasis and poor prognosis in BCa. Vascular endothelial growth factor receptor 3 (VEGFR3) and its ligands vascular endothelial growth factor C (VEGF‐C) and VEGF‐D have been described as key players in BCa‐induced lymphangiogenesis. However, the molecular mechanisms associated with lymphangiogenesis in BCa are not fully understood. In this review, we discuss how the local breast tumor microenvironment modulates the process of lymphangiogenesis to facilitate disease progression and provide a mechanistic insight into the complex formation of lymphatic vessels in BCa, highlighting the role of the VEGF‐C, D/VEGFR3 signaling axis, along with other molecular players. Additionally, the review discusses the versatile therapeutic potential targeting lymphangiogenesis in BCa and challenges that need to be overcome in the future. A complete understanding of lymphangiogenesis in BCa will open up new possibilities for targeted therapeutics that can potentially improve outcomes for BCa patients and the efficacy of current treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA.
- Department of Pathology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, Alabama, USA.
- Department of Biochemistry and Molecular Biology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, Alabama, USA.
ORCID-Profile: Chandrani Sarkar
Förderung
- Breast Cancer Research Foundation of Alabama (BCRFA)
- University of South Alabama (USA)
Zitieren
APA
Kola, B., Kakkat, S., Suman, P., Crouch, E., Chakroborty, D., & Sarkar, C. (2025). Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications. The FASEB Journal, 39(9). https://doi.org/10.1096/fj.202500024r
Vancouver
Kola B, Kakkat S, Suman P, Crouch E, Chakroborty D, Sarkar C. Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications. The FASEB Journal. 2025;39(9). doi:10.1096/fj.202500024r
BibTeX
@article{Kola2025,
author = {Kola, Brusi and Kakkat, Sooraj and Suman, Prabhat and Crouch, Emily and Chakroborty, Debanjan and Sarkar, Chandrani},
title = {Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {9},
doi = {10.1096/fj.202500024r}
}
EUVIMED